We recently demonstrated that cyclin G2 exerts tumor-suppressive effects by inhibiting epithelial-to-mesenchymal transition (EMT) via suppression of Wnt/ß-catenin signaling in ovarian cancer cells [18]. The gene discussed is CCNG2; the disease is ovarian carcinoma.